![Overview of current targeted therapy in gallbladder cancer | Signal Transduction and Targeted Therapy Overview of current targeted therapy in gallbladder cancer | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00324-2/MediaObjects/41392_2020_324_Fig1_HTML.png)
Overview of current targeted therapy in gallbladder cancer | Signal Transduction and Targeted Therapy
![Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer](https://f6publishing.blob.core.windows.net/6eea788a-8910-4b98-9e9d-5f0d78ab8b87/WJGS-14-1272-g004.png)
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer
![Gall Bladder Cancer | Padmavathi Gastro and Liver Hospital Madinaguda, Miyapur | Best liver transplant hospital in Hyderabad Gall Bladder Cancer | Padmavathi Gastro and Liver Hospital Madinaguda, Miyapur | Best liver transplant hospital in Hyderabad](http://padmavathigastro.com/assets/images/services/risk.jpg)
Gall Bladder Cancer | Padmavathi Gastro and Liver Hospital Madinaguda, Miyapur | Best liver transplant hospital in Hyderabad
![Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/768009/768009_Thumb_400.jpg)
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
![Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer](https://f6publishing.blob.core.windows.net/6eea788a-8910-4b98-9e9d-5f0d78ab8b87/WJGS-14-1272-g001.png)
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer
![Figure 1 from Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy | Semantic Scholar Figure 1 from Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/824500a250c83360b56301e35d71787842b66b9b/2-Figure1-1.png)
Figure 1 from Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy | Semantic Scholar
![Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI | Cancer Imaging | Full Text Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI | Cancer Imaging | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40644-020-00326-x/MediaObjects/40644_2020_326_Fig1_HTML.png)
Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI | Cancer Imaging | Full Text
![Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know | RadioGraphics Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021200087/asset/images/medium/rg.2021200087.va.gif)
Gallbladder Carcinoma and Its Differential Diagnosis at MRI: What Radiologists Should Know | RadioGraphics
![Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review | BMC Cancer | Full Text Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4969-2/MediaObjects/12885_2018_4969_Fig4_HTML.png)
Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review | BMC Cancer | Full Text
![The Multiple Molecular Signatures in Gallbladder Carcinoma: from Basic Studies to Clinical Application The Multiple Molecular Signatures in Gallbladder Carcinoma: from Basic Studies to Clinical Application](https://www.fortunejournals.com/fulltext-images/the-multiple-molecular-signatures-in-gallbladder-carcinoma-01.png)